XOMA Co. (NASDAQ:XOMAO – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 137 shares, a decrease of 52.8% from the April 30th total of 290 shares. Based on an average trading volume of 7,344 shares, the days-to-cover ratio is presently 0.0 days.
XOMA Stock Performance
Shares of XOMAO stock opened at $25.34 on Friday. The firm’s 50 day moving average price is $25.45 and its 200-day moving average price is $25.42. XOMA has a one year low of $24.86 and a one year high of $26.40.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Stories
- Five stocks we like better than XOMA
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
